Last reviewed · How we verify
NCT06774391: CV-UNEXPET/TC
CARDIOVASCular Unexpected fiNdings in patiEnts Undergoing eXecution of PET/tc
trial in Cardiovascular Disease Other in 1,000 participants. Completed in 31 December 2020.
31 December 2019
Quick facts
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 January 2017 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Italy |
Conditions studied
- Cardiovascular Disease Other — all drugs for Cardiovascular Disease Other →
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna — full company profile →
Who can join
18 and older, any sex, with Cardiovascular Disease Other. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this single-center observational study is to retrospectively evaluate incidental findings at the cardiovascular level in a selection of patients referred to the O.U. of Nuclear Medicine of Policlinco S.Orsola-Malpighi who underwent a PET/CT investigation. In particular, the present study is aimed to explore in such patients occasional findings of hypercapturing radiopharmaceutical findings specifically referred to: * infection inflammatory processes of implantable cardiac devices (ICDs, pacemakers); * phenomena affecting the atria during episodes of atrial fibrillation; * infection and inflammatory processes of cardiovascular structures (endocarditis, myocarditis, pericarditis, amyloidosis). Patients who performed PET/CT examination at the Sant'Orsola-Malpighi Nuclear Medicine O.U. during the period between 01/01/2017 and 31/12/2019 will be included in this registry. Any cardiovascular events that occurred within the Sant'Orsola-Malpighi Polyclinic setting and up to 3 months after the date of the PET/CT scan will be subsequently evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06774391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Disease Other
Currently open trials in the same condition.
- NCT06334003 — Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology · recruiting
- NCT06003023 — Congenital Heart Disease Physical Activity Lifestyle Study V.2 · NA · recruiting
- NCT05061108 — Linkage, Empowerment, and Access to Prevent Hypertension · NA · active not recruiting
Other IRCCS Azienda Ospedaliero-Universitaria di Bologna trials
Trials by the same sponsor.
- NCT06718049 — Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juveni · not yet recruiting
- NCT07490392 — Growth and Endocrinological Outcomes in Patients Who Underwent or Did Not Undergo Haematopoietic Stem Cell Transplantati · not yet recruiting
- NCT07483853 — Reliability and Validation of the WB-MRI Radiological Score in CRMO · recruiting
- NCT07479121 — These Studies Assess Surgeons' Physical and Ergonomic Workloads. Study 1 Compares Laparoscopic vs. Hugo RAS Robotic Appr · NA · not yet recruiting
- NCT07471009 — Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kinase Receptor Expression in Patients With Sq · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06774391 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Last refreshed: 14 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06774391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing